| 2026-03-25 |
股东大会：
将于2026-05-06召开股东大会
会议内容 ▼▲
- 1.To elect three nominees as Class III directors;
2.To approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;
5.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2026-03-25 |
详情>>
股本变动：
变动后总股本9203.42万股
|
| 2026-03-12 |
详情>>
内部人交易：
Cancelmi Daniel J股份增加6625.00股
|
| 2026-02-27 |
详情>>
业绩披露：
2025年年报每股收益-12.16美元,归母净利润-11.03亿美元,同比去年增长-531.42%
|
| 2026-02-25 |
财报披露：
美东时间 2026-02-25 盘前发布财报
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.82美元,归母净利润7474.70万美元,同比去年增长-66.48%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益0.42美元,归母净利润3850.10万美元,同比去年增长-75.14%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益0.09美元,归母净利润837.40万美元,同比去年增长-89.04%
|
| 2025-04-10 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To elect four nominees as Class II directors;
2.To approve an amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To approve, on a non-binding advisory basis, the frequency of a non-binding advisory vote on the compensation of our named executive officers;
5.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
6.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益2.79美元,归母净利润2.56亿美元,同比去年增长1279.73%
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益3.05美元,归母净利润2.73亿美元,同比去年增长43.28%
|
| 2024-10-30 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.87美元,归母净利润-7939.6万美元,同比去年增长-137.45%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益2.44美元,归母净利润2.23亿美元,同比去年增长380.87%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益1.69美元,归母净利润1.55亿美元,同比去年增长11.97%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益0.84美元,归母净利润7638.30万美元,同比去年增长15.71%
|
| 2024-04-09 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.To elect three nominees as Class I directors;
2.To approve an amendment to the Certificate of Incorporation to declassify the Board of Directors;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
5.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益-0.24美元,归母净利润-2166.7万美元,同比去年增长-107.93%
|
| 2023-04-07 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.To elect two nominees as Class III directors;
2.To approve an amendment and restatement of the Acadia Healthcare Company, Inc. Incentive Compensation Plan;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
5.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-04-08 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.To elect three nominees as Class II directors;
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-24 |
股东大会：
将于2021-05-06召开股东大会
会议内容 ▼▲
- 1.To elect three nominees as Class I directors;
2.To approve an amendment to the Acadia Healthcare Company, Inc. Incentive Compensation Plan;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
5.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-03-25 |
股东大会：
将于2020-05-07召开股东大会
会议内容 ▼▲
- 1.To elect two nominees as Class III directors;
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
4.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-03-23 |
复牌提示：
2020-03-23 09:39:46 停牌，复牌日期 2020-03-23 09:44:46
|
| 2019-03-21 |
股东大会：
将于2019-05-02召开股东大会
会议内容 ▼▲
- 1.To elect two nominees as Class II directors;
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
3.To approve, on a non-binding advisory basis, the frequency of a non-binding advisory vote on the compensation of our named executive officers;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
5.To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2018-03-23 |
股东大会：
将于2018-05-03召开股东大会
会议内容 ▼▲
- (1)To elect two nominees as Class I directors;
(2)To approve, on a non-binding advisory basis, the compensation of our named executive officers;
(3)To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
(4)To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2017-04-13 |
股东大会：
将于2017-05-25召开股东大会
会议内容 ▼▲
- 1. To elect three nominees as Class III directors;
2. To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to adopt a majority voting standard in uncontested director elections;
3. To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
5. To consider and act on a stockholder proposal relating to sustainability reporting, if properly presented at the meeting;
6. To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|
| 2016-04-08 |
股东大会：
将于2016-05-19召开股东大会
会议内容 ▼▲
- 1. To elect three nominees as Class II directors;
2. To approve an amendment to the Acadia Healthcare Company, Inc. Incentive Compensation Plan;
3. To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
5. To consider and act on a stockholder proposal to adopt a majority voting standard in uncontested director elections, if properly presented at the meeting;
6. To consider and act on a stockholder proposal relating to sustainability reporting, if properly presented at the meeting;
7. To transact any other business that properly comes before the Annual Meeting or any adjournments or postponements thereof.
|